Name: Schering-plough Corp. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

Schering-plough Corp.

Oct. 24 Quick Takes: Sumitovant’s $27 per share sweet enough for Myovant

BI’s Fine becomes president of R&D at EvolveImmune

Nektar to cut 70% of staff; Nuyten, Northcott to depart

Insilico rounds out C-suite as it readies for clinic, U.S. growth

Management tracks: Merck creates new commercial roles to follow Schechter's exit

NexImmune deal

Barer among investors acquiring NexImmune

Advising Israel

Sanofi's post-reconstruction era

Therapeutics: Viral protein 1 (VP1)